Study on GLP-1s and Breast Cancer 'Too Good to Be True'?

(MedPage Today) — Use of GLP-1 receptor agonists in breast cancer patients was associated with lower mortality and risk of recurrence in a retrospective study, but experts question the quality of the underlying data. At 10 years old, everyone’s risk…